DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

205.32 -2.04 (-0.98%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $205.32 -0.98%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $207.21
Previous Close $207.36
Daily Range $203.46 - $207.41
52-Week Range $106.00 - $211.57
Market Cap $69.0B
P/E Ratio 77.66
Dividend (Yield) $0.00 (0.0%)
Volume 1,485,122
Average Daily Volume 2,384,144
Current FY EPS $2.96

Sector

Healthcare

Industry

Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary Rss Feed

Can This Pharma Go From Good to Great?

Will Actavis' $66 billion merger with Allergan catapult this company from good to great? Or could a hidden risk derail this global powerhouse?

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog

Are Billions About to Be Made in Cosmetic Dermatology by 3 Companies?

Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog

Celsion Gains on Impressive Breast Cancer Study Data - Analyst Blog

Roche Collaborates with Astellas Pharma for Tissue Diagnostics - Analyst Blog

Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog

Abbott Labs, Sekisui Medical to Offer Coagulation Tests - Analyst Blog

Ironwood Has Plenty Of Market Development Work Ahead

Mylan Settles Patent Litigation Related to Pfizer's Viagra - Analyst Blog

Roche Acquires CAPP Medical to Strengthen Cancer Diagnosis - Analyst Blog

Roche Acquires CAPP Medical to Strengthen Cancer Diagnosis - Analyst Blog

See More VRX News...

VRX's Top Competitors

VRX $205.32 (-0.98%)
Current stock: VRX
JNJ $99.58 (-0.21%)
Current stock: JNJ
PFE $35.04 (-0.43%)
Current stock: PFE
NVS $102.46 (-0.82%)
Current stock: NVS